Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cybin Inc
N.CYBN
Alternate Symbol(s):
CYBN
Healthcare
Drug Manufacturers - Specialty & Generic
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary...
deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NEO:CYBN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(53)
•••
88guy88
X
View Profile
View Bullboard History
Post by
88guy88
on Dec 09, 2020 1:27pm
Overpriced....
its run too much in just a couple of days....needs to check back to under a buck
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Comment by
realitycheck00
on Dec 09, 2020 11:05am
RE:CyBin Acquisition
Dont think the market has even priced in this deal yet. Not a scientist by any means but looking at deuterated molecules does position Cybin leaps and bounds past competitors as all molecules
...more
(4)
•••
Jim1274
X
View Profile
View Bullboard History
Post by
Jim1274
on Dec 08, 2020 11:21am
CyBin Acquisition
So did Cybin actually just manage to buy a company with multiple patents and years of intellectual property for 6million shares?? Then an additional 6m shares “IF” they meet expectations..?? Sounds
...more
(3)
•••
Mil_Man54
X
View Profile
View Bullboard History
Comment by
Mil_Man54
on Dec 08, 2020 10:56am
RE:RED LIGHT HOLLAND $TRIP 🍄🍄🍄🍄🍄
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Comment by
realitycheck00
on Dec 07, 2020 1:50pm
RE:Stock dilution
How, the shares are locked up and the intrinsic value of the acquisition should be added in. MMED now nearly $1B market cap and Cybin in my opinion still has lots of room to go.
(53)
•••
88guy88
X
View Profile
View Bullboard History
Post by
88guy88
on Dec 07, 2020 10:53am
The price ran way up
from the 75 cent IPO and fell back to 65 and 70 cents of large volume at 70 cents and either they did not know about todays transaction or didn't care and got out price ran up into the
...more
(6)
•••
Streetbrain
X
View Profile
View Bullboard History
Comment by
Streetbrain
on Dec 07, 2020 10:05am
RE:Stock dilution
Its only 8M of Dilutation the rest is earned out of milestones which is very important for shareholders
(53)
•••
88guy88
X
View Profile
View Bullboard History
Post by
88guy88
on Dec 07, 2020 9:33am
Stock dilution
price should head back down with stock dilution
(15)
•••
realitycheck00
X
View Profile
View Bullboard History
Post by
realitycheck00
on Dec 07, 2020 9:21am
The M&A Train has left the station with CYBN
CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics as Part of its Commitment to Strategic Growth Cybin to host conference call today, December 7, 2020, at 5:00 p.m. ET
...more
(6)
•••
Streetbrain
X
View Profile
View Bullboard History
Post by
Streetbrain
on Dec 03, 2020 4:15pm
Big Close !!!!$CYBN
Cybin to the $2.00
(53)
•••
88guy88
X
View Profile
View Bullboard History
Post by
88guy88
on Dec 03, 2020 2:30pm
Consideration 3.4 million dollars
traded between 70 and 80 cents....perhaps early investors cashing out.....since then its been slowly building up but still cautious on the momentum strength.....quite a wide range in price daily
...more
(6)
•••
Streetbrain
X
View Profile
View Bullboard History
Post by
Streetbrain
on Dec 03, 2020 12:53pm
Q&A CEO DOUG DRYSDALE VIDEO
https://www.youtube.com/watch?v=PnZZQlv6NpY
(4)
•••
Jim1274
X
View Profile
View Bullboard History
Post by
Jim1274
on Dec 03, 2020 9:28am
CATALYST!!!
Cybin will be posted on the OTC and Frankfurt in the coming days/weeks as per CEO of the Neo Exchange!!
(53)
•••
88guy88
X
View Profile
View Bullboard History
Post by
88guy88
on Dec 02, 2020 10:13am
It begins
looks like it wants to test old pricing....also noticed this morning that someone did a bid of a penny over the ask price to try to artifically prop up the stock......that quite the indicator will
...more
(4)
•••
Jim1274
X
View Profile
View Bullboard History
Comment by
Jim1274
on Dec 01, 2020 3:19pm
RE:Rolling Over...back to 75 cents
Whole market down on investors moving over to weed plays amid possible legalization, it's holding pretty good for a newly listed company comparatively, should see some buyers tomorow after the q
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >